Brian Marr, MD, Joins Division of Ophthalmic Oncology at NewYork-Presbyterian/Columbia University Medical Center


Get Permission

Brian Marr, MD

Brian Marr, MD

Brian Marr, MD, has joined the Department of Ophthalmology at NewYork-Presbyterian/Columbia University Medical Center as Director of the Division of Ophthalmic Oncology. He will also serve as Professor of Ophthalmology at Columbia University Medical Center.

With Dr. Marr’s arrival, NewYork-Presbyterian/Columbia University Medical Center is establishing one of the largest and most comprehensive ocular melanoma programs in the country. Working alongside medical oncologists, he will serve a leadership role in the treatment of ocular melanoma, under the direction of Richard Carvajal, MD, Director of the Experimental Therapeutics/Phase I Program and Melanoma Service in Medical Oncology.

Clinical Experience

As one of the few ocular oncologists trained in all aspects of eye cancers, Dr. Marr’s clinical experience in treating these diseases is among the most extensive in the world. He has devised and performed thousands of surgical procedures on tumors of the eye, eyelid, orbit, and conjunctiva in adults, children, and infants. He also is one of the few surgeons experienced in intraocular tumor resection as well as advanced laser, radiation, and chemotherapy treatments. Finally, he is an expert in intra-arterial chemotherapy and other treatments for retinoblastoma, a tumor that arises in the light-sensitive cells that transmit images to the brain.

A board-certified ophthalmologist, Dr. Marr is a member of the American Medical Association and a board-certified fellow of the American Academy of Ophthalmology, for which he has lectured frequently. ■


Advertisement

Advertisement



Advertisement